Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Steven T. Harris · JAMA · 1999 · 2.5K citations

Medicine, Endocrinology, Bone Augmentation +16

Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy

Deborah Grady, David Herrington, Vera Bittner et al. · JAMA · 2002 · 1.9K citations

Medicine, Cardiology, Endocrinology +17

Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. <i>JAMA</i> 2002; 288(3): 321-333

Dr Ailsa Gebbie · Journal of Family Planning and Reproductive Health Care · 2002 · 1.2K citations · Full text

Medicine, Endocrinology, Gynecology +11

Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis

Nelson B. Watts, Steven T. Harris, Harry K. Genant et al. · New England Journal of Medicine · 1990 · 957 citations

Medicine, Endocrinology, Bone Metabolism +9